Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Costanza Di Chiara

Biographic Data

ID7618375
NAMECostanza Di Chiara
GIVEN NAMESCostanza
FAMILY NAMEDi Chiara
SIGNATUREDI CHIARA C
AFFILIATIONSUniversity of Padua
ORCID0000-0002-3586-0612
VERIFIEDYes
TOTAL WORKS5
TOTAL CITATIONS0
WORKS AS AUTHOR5
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2022
LATEST PUBLICATION YEAR2025
H-INDEX0
  • Exploring different modelling approaches to forecast the community acute respiratory infections burden in children

    Open Access•Riccardo Boracchini, Benedetta Canova et al.•ARTICLE•BMC Public Health•2025

    These findings suggest that exponential smoothing models are preferable for forecasting pediatric ARIs' burden trends in Italy. However, epidemiological data from the ongoing season are crucial for understanding whether residual pandemic effects continue affecting respiratory infection patterns

  • Early Use of Sotrovimab in Children

    Open Access•Costanza Di Chiara, Daniele Mengato et al.•ARTICLE•Children•2022

    For the first time, we report the well-tolerated use of sotrovimab in children under 12 years old. As the pandemic affects children across the globe, urgent data on sotrovimab dosing in children with a higher risk of developing severe COVID-19 are needed

  • Perceived Psychological Impact on Children and Parents of Experiencing Covid-19 Infection in One or More Family Members

    Open Access•Paola Costenaro, Costanza Di Chiara et al.•ARTICLE•Children•2022

    SARS-CoV-2 infection may impair behavior and mental health; we explored the psychological impact on parents and children who experienced COVID-19 within their families. A cross-sectional web-based survey was conducted on families attending the COVID-19 Follow-up Clinic at the Department for Women’s and Children’s Health, Padua (Italy). From April 2020 to August 2021, 75 surveys were collected from 66 families (97 parents and 129 children); almost…

  • Preliminary Evidence on Pulmonary Function after Asymptomatic and Mild Covid-19 in Children

    Open Access•Costanza Di Chiara, Silvia Carraro et al.•ARTICLE•Children•2022

    In our study, we observed that children and adolescents did not develop chronic respiratory symptoms and did not present lung function impairment after asymptomatic or mild SARS-CoV-2 infection

  • Daptomycin for Treatment of S. Epidermidis Endocarditis in an Extremely Preterm Neonate—Outcome and Perspectives

    Open Access•Chiara Minotti, Ilaria Zuccon et al.•ARTICLE•Children•2022

    With a considerable morbidity and mortality burden, infective endocarditis still represents a challenge for clinicians. This is a case of persistent Staphylococcus epidermidis endocarditis in an extremely preterm newborn. The infection, initially treated with vancomycin, was successfully cured with daptomycin. Its use was safe and effective, ensuring a complete remission without adverse effects

No prominent works on this page.

  • Early Use of Sotrovimab in Children

    Open Access•Costanza Di Chiara, Daniele Mengato et al.•ARTICLE•Children•2022

    For the first time, we report the well-tolerated use of sotrovimab in children under 12 years old. As the pandemic affects children across the globe, urgent data on sotrovimab dosing in children with a higher risk of developing severe COVID-19 are needed

  • Perceived Psychological Impact on Children and Parents of Experiencing Covid-19 Infection in One or More Family Members

    Open Access•Paola Costenaro, Costanza Di Chiara et al.•ARTICLE•Children•2022

    SARS-CoV-2 infection may impair behavior and mental health; we explored the psychological impact on parents and children who experienced COVID-19 within their families. A cross-sectional web-based survey was conducted on families attending the COVID-19 Follow-up Clinic at the Department for Women’s and Children’s Health, Padua (Italy). From April 2020 to August 2021, 75 surveys were collected from 66 families (97 parents and 129 children); almost…

  • Preliminary Evidence on Pulmonary Function after Asymptomatic and Mild Covid-19 in Children

    Open Access•Costanza Di Chiara, Silvia Carraro et al.•ARTICLE•Children•2022

    In our study, we observed that children and adolescents did not develop chronic respiratory symptoms and did not present lung function impairment after asymptomatic or mild SARS-CoV-2 infection

  • Daptomycin for Treatment of S. Epidermidis Endocarditis in an Extremely Preterm Neonate—Outcome and Perspectives

    Open Access•Chiara Minotti, Ilaria Zuccon et al.•ARTICLE•Children•2022

    With a considerable morbidity and mortality burden, infective endocarditis still represents a challenge for clinicians. This is a case of persistent Staphylococcus epidermidis endocarditis in an extremely preterm newborn. The infection, initially treated with vancomycin, was successfully cured with daptomycin. Its use was safe and effective, ensuring a complete remission without adverse effects

  • Exploring different modelling approaches to forecast the community acute respiratory infections burden in children

    Open Access•Riccardo Boracchini, Benedetta Canova et al.•ARTICLE•BMC Public Health•2025

    These findings suggest that exponential smoothing models are preferable for forecasting pediatric ARIs' burden trends in Italy. However, epidemiological data from the ongoing season are crucial for understanding whether residual pandemic effects continue affecting respiratory infection patterns

Internal Medicine (5 works) · Medicine (5 works) · Pediatrics (4 works) · Coronavirus disease 2019 (COVID-19 (3 works) · Infectious disease (medical specialty (3 works) · Asymptomatic (2 works) · Disease (2 works) · Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 (2 works) · 2019-20 coronavirus outbreak (1 work) · Adverse effect (1 work)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae